Those who lost at least 5% of their initial body weight continued taking Wegovy for another three months, at which point they had lost a total of 25 pounds
This new analysis presented at ECO, focused on the difference in early cardiovascular events with semaglutide versus placebo from randomisation up to 12 months, with a focus on 3 and 6 months, to better understand the drugs effects, time to cardiovascular benefit, as well as predictors that might help identify patients at risk for early cardiovascular events
Further investigation and research are required to determine whether there is a real causal relationship
The frequency of glutathione treatments depends on your health goals and how your body responds to therapy
Side effects are generally rare and often resolve with consistent use
No, small air bubbles in GLP-1 injections administered subcutaneously (under the skin) cannot cause air embolism, as they are absorbed harmlessly by the fatty tissue and do not enter the bloodstream